David Kabat, Ph.D.

Head Shot of David Kabat
click here

Selected Publications

"Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry," Proceedings of the National Academy of Sciences of the United States of America (Vol: 109, Issue: 20, Page 7829-7834) - 2012

"Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions," Journal of Virology (Vol: 84, Issue: 6, Page 3106-3110) - 2010

"Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1," Journal of Virology (Vol: 83, Issue: 16, Page 8289-8292) - 2009

"Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism," Journal of Virology (Vol: 82, Issue: 2, Page 987-998) - 2008

"An Allosteric Rheostat in HIV-1 gp120 Reduces CCR5 Stoichiometry Required for Membrane Fusion and Overcomes Diverse Entry Limitations," Journal of Molecular Biology (Vol: 374, Issue: 1, Page 64-79) - 2007


Back to faculty list


  Email David Kabat

503 494-8442